Tejal Desai, PhD, and colleagues took inspiration from the structure of DNA to engineer a biomaterial that promises to improve CAR-T cell therapy for various cancers.
Advance opens up new possibilities for CAR T-cell therapy to treat a variety of cancers
A 3D printed model of a SARS-CoV-2 viral particle (blue) dotted with the spike protein (red) that enables the virus to infect human cells. The spike protein is the target of research efforts to prevent and treat COVID-19.
Team efforts at the School and beyond produce two potential treatments for COVID-19.
National Institute of Allergy and Infectious Diseases (NIAID)
Middle East respiratory syndrome coronavirus (MERS-CoV) viral particles under an electron microscopic.
“This is looking across coronaviruses and finding the commonalities so we’re in a better position to attack SARS3 when it comes,” said Nevan Krogan, the director of QBI.
